BioSante Pharmaceuticals to Present at Upcoming Conferences
May 16 2007 - 8:00AM
Business Wire
BioSante Pharmaceuticals (AMEX: BPA) today announced that Stephen
M. Simes, president and chief executive officer, will present a
corporate overview at two upcoming conferences. The conferences
are: The CIBC World Markets Israeli Conference on May 20, 2007 at
3:55 p.m. local time at the David Intercontinental, Tel Aviv. The
RedChip Small-Cap Investor Conference on May 30, 2007 at 10:30 p.m.
local time at the Ritz Carlton in San Francisco. A live audio
webcast of BioSante�s presentation at the RedChip conference can be
accessed on the internet by visiting www.biosantepharma.com. An
archive of this presentation will be available at the same address.
The CIBC World Markets Israeli Conference will have over 45
presentations by worldwide technology leaders. The RedChip
Small-Cap Investor Conference will feature CEOs from fifty
companies. About BioSante Pharmaceuticals, Inc. BioSante is
developing a pipeline of hormone therapy products to treat both men
and women. These hormone therapy products are gel formulations for
transdermal administration that deliver bio-identical estradiol and
testosterone. BioSante's lead products include Elestrin� (estradiol
gel), developed through U.S. Food and Drug Administration (FDA)
approval by BioSante, indicated for the treatment of
moderate-to-severe vasomotor symptoms associated with menopause,
and LibiGel� (transdermal testosterone gel) in Phase III
development for the treatment of female sexual dysfunction (FSD).
The current market in the U.S. for estrogen and testosterone
products is approximately $2.5 billion. The company also is
developing its calcium phosphate nanotechnology (CaP) for novel
vaccines, including hepatitis B, avian flu and biodefense vaccines
for toxins such as anthrax, as well as a system for delivering
drugs via alternative routes of administration. Additional
information is available online at: www.biosantepharma.com.
Biosante Pharma (AMEX:BPA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biosante Pharma (AMEX:BPA)
Historical Stock Chart
From Jul 2023 to Jul 2024